ProfileGDS5678 / 1423669_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 112.065599
GSM967853U87-EV human glioblastoma xenograft - Control 211.762899
GSM967854U87-EV human glioblastoma xenograft - Control 312.437999
GSM967855U87-EV human glioblastoma xenograft - Control 411.72799
GSM967856U87-EV human glioblastoma xenograft - Control 512.291699
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.013399
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.510399
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.772699
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.631299
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 111.640599
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 211.132499
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 311.302299
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 411.876599
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.904899